| scholarly article | Q13442814 |
| P50 | author | Partow Kebriaei | Q104745054 |
| Amin M Alousi | Q104745055 | ||
| Gabriela Rondon | Q114427983 | ||
| Rima M Saliba | Q114428014 | ||
| Laura Worth | Q114428072 | ||
| John McMannis | Q116793080 | ||
| Doyle Bosque | Q117236295 | ||
| Indreshpal Kaur | Q117236311 | ||
| Roy B. Jones | Q122694370 | ||
| Chitra Hosing | Q37840480 | ||
| Laurence J. Cooper | Q71696785 | ||
| Yago Nieto | Q85372325 | ||
| Muzaffar Qazilbash | Q87088891 | ||
| Simrit Parmar | Q87373603 | ||
| Elizabeth J Shpall | Q87373605 | ||
| Stefan O Ciurea | Q87848230 | ||
| Nina Shah | Q88085681 | ||
| Betul Oran | Q88085684 | ||
| Richard E Champlin | Q89187648 | ||
| Uday R Popat | Q89893020 | ||
| Jeffrey J Molldrem | Q90320544 | ||
| Mark F Munsell | Q90326364 | ||
| Mary Eapen | Q90465654 | ||
| Catherine M Bollard | Q91774704 | ||
| Martin Körbling | Q103405750 | ||
| P2093 | author name string | Mary Horowitz | |
| Marcos de Lima | |||
| Borje S Andersson | |||
| Simon N Robinson | |||
| Ian McNiece | |||
| Paul J Simmons | |||
| Ila Maewal | |||
| P2860 | cites work | Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 |
| Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution | Q33642298 | ||
| Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial | Q33861192 | ||
| Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors | Q33951486 | ||
| Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood | Q34374133 | ||
| Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis | Q35185685 | ||
| Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice. | Q35962339 | ||
| Umbilical Cord Blood (UCB) transplantation: an alternative to the use of unrelated volunteer donors? | Q37007259 | ||
| Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation | Q37209033 | ||
| Twenty-five years of peripheral blood stem cell transplantation | Q37860796 | ||
| 1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
| Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. | Q41675626 | ||
| Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells | Q42160266 | ||
| Human and mouse hematopoietic colony-forming cell assays. | Q45054374 | ||
| Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications | Q45736128 | ||
| Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. | Q46348876 | ||
| Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study | Q48480090 | ||
| Dynamic changes in cellular and microenvironmental composition can be controlled to elicit in vitro human hematopoietic stem cell expansion. | Q51340195 | ||
| Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. | Q51359131 | ||
| Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells. | Q52195487 | ||
| History of the clinical use of umbilical cord blood hematopoietic cells. | Q53286517 | ||
| Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy | Q56777948 | ||
| Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia | Q58865943 | ||
| CD34 expression by stromal precursors in normal human adult bone marrow | Q67704482 | ||
| The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering | Q71558484 | ||
| Hematopoietic stem-cell transplants using umbilical-cord blood | Q74022901 | ||
| Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors | Q74022952 | ||
| Transplantation of ex vivo expanded cord blood | Q74596740 | ||
| Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units | Q78531436 | ||
| Outcomes of transplantation in children with acute leukaemia | Q80459448 | ||
| Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes | Q83361036 | ||
| Umbilical cord blood transplantation | Q83422600 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2305-2315 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Cord-blood engraftment with ex vivo mesenchymal-cell coculture | |
| P478 | volume | 367 |
| Q40965643 | 3D models of the hematopoietic stem cell niche under steady-state and active conditions. |
| Q43258035 | A Novel High-Throughput Screening Platform Reveals an Optimized Cytokine Formulation for Human Hematopoietic Progenitor Cell Expansion. |
| Q91844297 | A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation |
| Q48134193 | A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies. |
| Q47228036 | A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning. |
| Q91195052 | A resurgence of cord blood transplantation? |
| Q41053495 | A small-molecule/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation |
| Q92850019 | Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models |
| Q27014857 | Advances in haplo-identical stem cell transplantation in adults with high-risk hematological malignancies |
| Q26824305 | Advances in umbilical cord blood manipulation-from niche to bedside |
| Q43668394 | Advances in umbilical cord blood transplant: an overview of the 12th International Cord Blood Symposium, San Francisco, 5-7 June 2014. |
| Q38248427 | Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective |
| Q38199056 | Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: are we closer to knowing who needs it? |
| Q28080943 | Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia |
| Q30252339 | Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017! |
| Q26799456 | Alternative Donor Transplantation for Acute Myeloid Leukemia |
| Q47614526 | Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease. |
| Q92954779 | Are we underutilizing bone marrow and cord blood? Review of their role and potential in the era of cellular therapies |
| Q39006110 | Awareness of cord blood collection and the impact on banking |
| Q37443125 | Background and future considerations for human cord blood hematopoietic cell transplantation, including economic concerns |
| Q87067058 | Banking on cord blood stem cells |
| Q36115699 | Better allele-level matching improves transplant-related mortality after double cord blood transplantation. |
| Q35568527 | Biology of BM failure syndromes: role of microenvironment and niches |
| Q35591760 | Blood and marrow transplant clinical trials network state of the Science Symposium 2014 |
| Q92152784 | Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders |
| Q38968875 | Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery |
| Q30854127 | Bone marrow niche-mimetics modulate HSPC function via integrin signaling |
| Q64105462 | Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity |
| Q50594329 | CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants. |
| Q64104503 | CD34 cell content of 126 341 cord blood units in the US inventory: implications for transplantation and banking |
| Q37606482 | Cellular complexity of the bone marrow hematopoietic stem cell niche |
| Q38586429 | Cellular engineering and therapy in combination with cord blood allografting in pediatric recipients |
| Q47261441 | Characterization of the growth modulatory activities of osteoblast conditioned media on cord blood progenitor cells. |
| Q37196107 | Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant? |
| Q40618397 | Chronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood transplantation |
| Q42184255 | Clonal Dominance With Retroviral Vector Insertions Near the ANGPT1 and ANGPT2 Genes in a Human Xenotransplant Mouse Model |
| Q47787016 | Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation |
| Q34978763 | Co-transplantation with mesenchymal stem cells expressing a SDF-1/HOXB4 fusion protein markedly improves hematopoietic stem cell engraftment and hematogenesis in irradiated mice |
| Q52730545 | Cohort-Controlled Comparison of Umbilical Cord Blood Transplantation Using Carlecortemcel-L, a Single Progenitor-Enriched Cord Blood, to Double Cord Blood Unit Transplantation. |
| Q38986290 | Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells |
| Q48199548 | Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia |
| Q30366297 | Complement fragment 3a priming of umbilical cord blood progenitors: safety profile. |
| Q37255041 | Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine |
| Q34601968 | Concise review: umbilical cord blood transplantation: past, present, and future |
| Q38142167 | Cord Blood Transplantation: Can We Make it Better? |
| Q64968638 | Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. |
| Q38696346 | Cord blood transplant for acute myeloid leukaemia |
| Q89623565 | Cord blood transplantation for bone marrow failure syndromes: state of art |
| Q38780874 | Cord blood transplantation: rewind to fast forward |
| Q33911314 | Cord-Blood Transplantation in Patients with Minimal Residual Disease |
| Q39031953 | Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results |
| Q51003420 | Cryopreservation of cord blood CD34+ cells before or after thrombopoietin expansion differentially affects early platelet recovery in NOD SCID mice. |
| Q38155240 | Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation |
| Q88426253 | Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD |
| Q40025549 | Direct bone marrow HSC transplantation enhances local engraftment at the expense of systemic engraftment in NSG mice. |
| Q47632499 | Dissection of Signaling Events Downstream of the c-Mpl Receptor in Murine Hematopoietic Stem Cells Via Motif-Engineered Chimeric Receptors. |
| Q37583700 | Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells |
| Q33456839 | Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice |
| Q53315058 | Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma. |
| Q30415126 | Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia |
| Q38105635 | Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation |
| Q90198395 | Emerging strategies for enhancing the homing of hematopoietic stem cells to the bone marrow after transplantation |
| Q90581031 | Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats |
| Q35583385 | Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation |
| Q49297598 | Engineered Human Stem Cell Microenvironments. |
| Q33766995 | Engineering cord blood to improve engraftment after cord blood transplant |
| Q96576928 | Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin |
| Q36036346 | Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen |
| Q34315848 | Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.). |
| Q47230830 | Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling. |
| Q36984624 | Enhancing the efficacy of engraftment of cord blood for hematopoietic cell transplantation |
| Q40064521 | Epigenetic reprogramming induces the expansion of cord blood stem cells |
| Q38196514 | Epithelial and mesenchymal stem cells from the umbilical cord lining membrane |
| Q55279151 | Evaluating Interaction of Cord Blood Hematopoietic Stem/Progenitor Cells with Functionally Integrated Three-Dimensional Microenvironments. |
| Q48116992 | Ex Vivo Expansion of CD34+ CD90+ CD49f+ Hematopoietic Stem and Progenitor Cells from Non-enriched Umbilical Cord Blood with Azole Compounds. |
| Q38994507 | Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Umbilical Cord Blood |
| Q50901338 | Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation. |
| Q50645498 | Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery. |
| Q38561480 | Ex vivo expansion of hematopoietic stem cells |
| Q35563121 | Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers |
| Q38187494 | Ex vivo production of platelets from stem cells |
| Q51121443 | Expression of Surface Molecules in Human Mesenchymal Stromal Cells Co-Cultured with Nucleated Umbilical Cord Blood Cells. |
| Q89535287 | Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy |
| Q53281888 | Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro. |
| Q91841922 | Gene therapy of hematological disorders: current challenges |
| Q36702752 | General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation |
| Q37602625 | Generation of mesenchymal stromal cells from cord blood: evaluation of in vitro quality parameters prior to clinical use. |
| Q36605814 | Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application |
| Q64240820 | Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives |
| Q34603339 | Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2. |
| Q48324190 | Going home for the holidays? Take a shortcut! |
| Q51803668 | HSC Niche Biology and HSC Expansion Ex Vivo. |
| Q95936611 | Haematopoietic stem cell self-renewal in vivo and ex vivo |
| Q34232835 | Haploidentical vs cord blood transplantation for adults with acute myelogenous leukemia |
| Q92882734 | Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning |
| Q48589365 | Hematopoietic Niche - Exploring Biomimetic Cues to Improve the Functionality of Hematopoietic Stem/Progenitor Cells |
| Q26771763 | Hematopoietic stem cell expansion and generation: the ways to make a breakthrough |
| Q34625467 | Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions |
| Q36622322 | High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia |
| Q49218292 | High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation. |
| Q88141016 | Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo |
| Q26765622 | How to Improve Cord Blood Engraftment? |
| Q92783187 | Human Fetal Bone Marrow-Derived Mesenchymal Stem Cells Promote the Proliferation and Differentiation of Pancreatic Progenitor Cells and the Engraftment Function of Islet-Like Cell Clusters |
| Q54461111 | Human Mesenchymal Stem/Stromal Cells from Umbilical Cord Blood and Placenta Exhibit Similar Capacities to Promote Expansion of Hematopoietic Progenitor Cells In Vitro. |
| Q38675888 | Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology |
| Q50210848 | Human mesenchymal stem cells promote CD34+ hematopoietic stem cell proliferation with preserved red blood cell differentiation capacity |
| Q89839781 | Identification of osteolineage cell-derived extracellular vesicle cargo implicated in hematopoietic support |
| Q41263076 | Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor |
| Q38728525 | Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly. |
| Q38210863 | Improved human mesenchymal stem cell isolation. |
| Q38194133 | Improving engraftment and immune reconstitution in umbilical cord blood transplantation |
| Q60475693 | Intra-osseous Co-transplantation of CD34-selected Umbilical Cord Blood and Mesenchymal Stromal Cells |
| Q91556007 | Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study |
| Q64251958 | Liver Sinusoidal Endothelial Cells Promote the Expansion of Human Cord Blood Hematopoietic Stem and Progenitor Cells |
| Q36253327 | Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells |
| Q40045793 | Long-term culture and differentiation of porcine red bone marrow hematopoietic cells co-cultured with immortalized mesenchymal cells |
| Q44756831 | Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database |
| Q33864607 | Low rate of infusional toxicity after expanded cord blood transplantation. |
| Q88390009 | M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion |
| Q61657666 | Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation |
| Q33755190 | Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation? |
| Q36706478 | Mesenchymal Stem Cell-Derived Microvesicles Support Ex Vivo Expansion of Cord Blood-Derived CD34(+) Cells |
| Q53092701 | Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation. |
| Q34422955 | Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. |
| Q36288646 | Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells). |
| Q26775513 | Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation |
| Q38808411 | Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment |
| Q38658670 | Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications |
| Q42069315 | MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation |
| Q27021093 | Minireview: complexity of hematopoietic stem cell regulation in the bone marrow microenvironment |
| Q34175568 | Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies |
| Q37197917 | Multiple allogeneic progenitors in combination function as a unit to support early transient hematopoiesis in transplantation |
| Q42631262 | Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. |
| Q40214885 | Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia. |
| Q35628739 | New frontiers in pediatric Allo-SCT. |
| Q35797189 | No Synergistic Effect of Cotransplantation of MSC and Ex Vivo TPO-Expanded CD34(+) Cord Blood Cells on Platelet Recovery and Bone Marrow Engraftment in NOD SCID Mice |
| Q26772216 | Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials |
| Q38816505 | Novel approaches for preventing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation |
| Q39031745 | Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy |
| Q57167167 | On the Way to Platelet Production |
| Q57166306 | On the way to in vitro platelet production |
| Q38747929 | Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies |
| Q38815488 | Optimizing autologous cell grafts to improve stem cell gene therapy |
| Q50476329 | Parathyroid hormone enhances hematopoietic expansion via upregulation of cadherin-11 in bone marrow mesenchymal stromal cells. |
| Q47138648 | Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders |
| Q55331096 | Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol. |
| Q64976532 | Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide. |
| Q36938847 | Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft |
| Q38743140 | Phase II study of intrabone single unit cord blood transplantation for hematological malignancies |
| Q35140111 | Pleiotrophin mediates hematopoietic regeneration via activation of RAS. |
| Q37263182 | Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation |
| Q58415085 | Quantitative and Qualitative Immune Reconstitution Following Umbilical Cord Blood Transplantation |
| Q41279525 | Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells. |
| Q48246032 | Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee |
| Q38172271 | Remestemcel-L for acute graft-versus-host disease therapy |
| Q41411372 | Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia |
| Q33580598 | Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion. |
| Q52571381 | Synergistic Integration of Mesenchymal Stem Cells and Hydrostatic Pressure in the Expansion and Maintenance of Human Hematopoietic/Progenitor Cells. |
| Q49332525 | The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate. |
| Q51233542 | The Mesenchymal Precursor Cell Marker Antibody STRO-1 Binds to Cell Surface Heat Shock Cognate 70. |
| Q41911583 | The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation |
| Q36627127 | The hematopoietic system in the context of regenerative medicine |
| Q38682154 | The human and murine hematopoietic stem cell niches: are they comparable? |
| Q39012031 | The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies. |
| Q34483172 | The role and potential of umbilical cord blood in an era of new therapies: a review |
| Q34551183 | The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation |
| Q89526139 | Thermoresponsive Inverted Colloidal Crystal Hydrogel Scaffolds for Lymphoid Tissue Engineering |
| Q34751263 | Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice |
| Q38104287 | To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century |
| Q47838233 | Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation. |
| Q40258805 | Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization |
| Q30352323 | Umbilical Cord Blood Transplantation: Challenges and Future Directions. |
| Q38510475 | Umbilical cord blood donation: public or private? |
| Q33808209 | Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment |
| Q38514503 | Umbilical cord blood graft engineering: challenges and opportunities. |
| Q44116224 | Umbilical cord blood transplant: expanding the options |
| Q34344669 | Umbilical cord blood transplantation: the first 25 years and beyond |
| Q26853559 | Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants |
| Q40199108 | Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remission. |
| Q57518103 | Unrelated cord blood and bone marrow transplantation in pediatric leukemia |
| Q41589103 | Update on umbilical cord blood transplantation |
| Q55418977 | VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion. |
| Q28655924 | Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature |
| Q59443482 | Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies |
| Q39010662 | Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review |
| Q91729279 | Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells |
| Q35586490 | Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures. |
Search more.